Overcoming the ongoing challenges for rare disease patients in the UK

Gillian Molloy, Director of Market Access at AscellaHealth, examines the rare disease landscape in the UK, including progress in improving patient care and challenges in diagnostics and the development of new treatments

Rare conditions currently affect fewer than one in every 2,000 people across the UK, but collectively, one in 17 people will be affected at some point in their lifetime.

To read more, click here.